Based on the GEPIA2 database, we found that patients with high SCARB1 expression had a significantly poorer prognosis in the human head and neck squamous carcinoma (HNSCC) (Fig. 3A). This evidence concerns the gene SCARB1 and head and neck squamous cell carcinoma.